EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Injectable Estradiol Use in Transgender and Gender-Diverse Individuals throughout the United States

Aaron L Misakian iD, Carly E Kelley, Erika A Sullivan, Julia J Chang, Gagandeep Singh, Sarah Kokosa, Jonathan Avila, Holly Cooper, Jane W Liang, Bren Botzheim, Meg Quint, Athavi Jeevananthan und 19 weitere

The Journal of Clinical Endocrinology & Metabolism · 07.08.2025 · 110 (9) · e2898-e2907

DOI: 10.1210/clinem/dgaf015 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 11.01.2025. Verfasst von Aaron L Misakian und 30 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Endocrinology and Diabetes, Stanford University School of Medicine, Stanford, CA 94304, USA. Hauptthemen laut MEDLINE: Estradiol, Transgender Persons. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, University of Utah Department of Family and Preventive Medicine Health Studies Fund, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Guidelines for use of injectable estradiol esters (valerate [EV] and cypionate [EC]) among transgender and gender-diverse (TGD) individuals designated male at birth vary considerably, with many providers noting supraphysiologic serum estradiol concentrations based on current dosing recommendations.

Objectives

This work aimed to 1. determine the dose of injectable estradiol (subcutaneous [SC] and intramuscular [IM]) needed to reach guideline-recommended estradiol concentrations for TGD adults using EC/EV; 2. describe the relationship between estradiol concentration relative to timing/dose of last estradiol injection and other covariates; and 3. determine dosing differences between IM/SC EV/EC.

Methods

A cross-sectional retrospective study was conducted across 6 US medical centers including TGD adults on same-dose injectable estradiol for more than 75 days, with confirmed timing of estradiol concentration relative to last injection, from January 1, 2019 to December 31, 2023. Descriptive statistics were used to describe patient characteristics and weighted linear mixed models to evaluate relationship between various covariates and estradiol concentration.

Results

Data from 562 patients were included. Among those injecting every 7 days who reached the guideline-recommended estradiol concentration (n = 131, 27.5%), the median estradiol dose was 4.0 mg (interquartile range, 3.0-5.0 mg). Among all patients, the majority reached supraphysiologic estradiol concentrations (>200 pg/mL [>734 pmol/L]) while dose and timing in the injection cycle were significant covariates for the estradiol concentration. There were no significant dosing differences between IM/SC EV/EC.

Conclusion

Injectable estradiol esters effectively reach guideline-recommended estradiol concentrations but at lower doses than previously recommended. Estradiol concentrations are best interpreted relative to timing of last injection. Route of administration and type of ester do not significantly affect estradiol concentrations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EstradiolTransgender PersonsHumansMaleFemaleRetrospective StudiesCross-Sectional StudiesAdultUnited StatesInjections, IntramuscularMiddle AgedInjections, SubcutaneousYoung Adult

Stichwörter der Autor:innen

estradiol cypionateestradiol injectionsestradiol valerategender-affirming hormone therapytransgender

Substanzen

Estradiol

Autor:innen und Institutionen

  • Division of Pediatric Endocrinology and Diabetes, Stanford University School of Medicine, Stanford, CA 94304, USA.
  • Division of Endocrinology, Metabolism, and Nutrition, Duke University Medical Center, Durham, NC 27710, USA.
  • Department of Family and Preventive Medicine, University of Utah, School of Medicine, Salt Lake City, UT 84108, USA.
  • Division of Endocrinology, Gerontology and Metabolism, Stanford University School of Medicine, Stanford, CA 94304, USA.
  • Department of Family Medicine and Community Health, University of Minnesota, Minneapolis, MN 55455, USA.
  • Division of Adolescent Medicine, Stanford University School of Medicine, Stanford, CA 94304, USA.

ORCID-Profile: Aaron L Misakian

Förderung

  • NIDDK NIH HHS
  • University of Utah Department of Family and Preventive Medicine Health Studies Fund
  • National Institutes of Health

Zitieren

APA

Misakian, A. L., Kelley, C. E., Sullivan, E. A., Chang, J. J., Singh, G., Kokosa, S., Avila, J., Cooper, H., Liang, J. W., Botzheim, B., Quint, M., Jeevananthan, A., Chi, E., Harmer, M., Hiatt, L., Kowalewski, M., Steinberg, B., Tausinga, T., Tanner, H., …, & Ariel, D. (2025). Injectable Estradiol Use in Transgender and Gender-Diverse Individuals throughout the United States. The Journal of Clinical Endocrinology & Metabolism, 110(9), e2898-e2907. https://doi.org/10.1210/clinem/dgaf015

Vancouver

Misakian AL, Kelley CE, Sullivan EA, Chang JJ, Singh G, Kokosa S, et al. Injectable Estradiol Use in Transgender and Gender-Diverse Individuals throughout the United States. The Journal of Clinical Endocrinology & Metabolism. 2025;110(9):e2898-e2907. doi:10.1210/clinem/dgaf015

BibTeX
@article{Misakian2025,
  author = {Misakian, Aaron L and Kelley, Carly E and Sullivan, Erika A and Chang, Julia J and Singh, Gagandeep and Kokosa, Sarah and Avila, Jonathan and Cooper, Holly and Liang, Jane W and Botzheim, Bren and Quint, Meg and Jeevananthan, Athavi and Chi, Ellenor and Harmer, Madison and Hiatt, Laurel and Kowalewski, Michaela and Steinberg, Benjamin and Tausinga, Telisha and Tanner, Hannah and Ho, Tiffany F and Mark, Bayarmaa and Zenger, Brian and Hu, Sophia and Gebregzabheir, Amanuail and Penny, Justin M and Loeb, Danielle F and Strickland, Tyler and Iwamoto, Sean J and Rothman, Micol S and Hamnvik, Ole-Petter R and Ariel, Danit},
  title = {Injectable Estradiol Use in Transgender and Gender-Diverse Individuals throughout the United States},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  volume = {110},
  number = {9},
  pages = {e2898--e2907},
  doi = {10.1210/clinem/dgaf015}
}
Kostenlos starten →